Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.

Marja-Riitta TaskinenNiina MatikainenElias BjörnsonSanni SöderlundJussi InkeriAntti HakkarainenHelka ParviainenCarina SihlbomAnnika ThorsellLinda AnderssonMartin AdielsChris J PackardJan Borén

Published in: Diabetologia (2023)

ClinicalTrials.gov NCT02948777.

Keyphrases

cardiovascular disease
coronary artery disease
low density lipoprotein
type diabetes
cardiovascular events
stem cells
mesenchymal stem cells
breast cancer risk